Östersunds Sjukhus

Östersund 831 83

1 studies enrolling now · 2 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Diabetes Mellitus, Type 1, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke

Studies at this site

• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed